References
- Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995; 45 (1): 8–30 [Erratum, CA Cancer J Clin 1995; 45(2): 127–8]
- Rex DK, Lehman GA, Hawes RH, et al. Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology 1991; 100(1): 64–7
- Itzkowitz SH, Kim YS. Polyps and benign neoplasms of the colon. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal disease: pathophysiology, diagnosis, management. 5th ed. Philadelphia: Saunders, 1993: 1402–30
- Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 329(27): 1977–81
- Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319(9): 525–32
- Ryan ME, Norfleet RG, Kirchner JP, et al. The significance of diminutive colonic polyps found at flexible sigmoidoscopy. Gastroinrest Endose 1989; 35(2): 85–9
- Rex DK, Smith JJ, Ulbright TM, et al. Distal colonic hyperplastic polyps do not predict proximal adenomas in asymptomatic average-risk subjects. Gastroenterology 1992; 102(1): 317–9
- Lynch HT, Smyrk T, Watson P, et al. Hereditary colorectal cancer. Semin Oncol 1991; 18(4): 337–66
- Vasen HF, Mecklin JP, Khan PM, et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34(5): 424–5
- Lynch HT, Smyrk TC, Watson P, et al. Hereditary flat adenoma syndrome: a variant of familial adenomatous polyposis? Dis Colon Rectum 1992; 35(5): 411–21
- Giovannucci E, Willett WC. Dietary factors and risk of colon cancer. Ann Med 1994; 26(6): 443–52
- Greenberg ER, Baron JA, Freeman DH Jr, et al. Reduced risk of large-bowel adenomas among aspirin users. J Natl Cancer Inst 1993; 85(11): 912–6
- Lieberman D. Cost-effectiveness of colon cancer screening. Am J Gastroenterol 1991; 86(12): 1789–94
- Gelfand DW, Ott DJ. The economic implications of radiologic screening for colonic cancer. Am J Roentgenol 1991; 156(5): 939–43
- Sel by JV, Friedman GD, Quesenberry CP Jr, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326(10): 653–7
- Gnauck R, Macrae FA, Fleisher M. How to perform the fecal occult blood test. CA Cancer J Clin 1984; 34(3): 134–47
- Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328 (19): 1365–71 [Erratum, N Engl J Med 1993: 329(9): 672]
- Winawer SJ, St John DJ, Bond JH, et al. Prevention of colorectal cancer: guidelines based on new data. WHO Collaborating Center for the Prevention of Colorectal Cancer. Bull World Health Organ 1995; 73(1): 7–10
- Levin B, Murphy GP. Revision in American Cancer Society recommendations for the early detection of colorectal cancer. CA Cancer J Clin 1992; 42(5): 296–9
- Lieberman DA. Targeted colon cancer screening: a concept whose time has almost come. Am J Gastroenterol 1992; 87(9): 1085–93